pe.onwuka
TL2 Moderator · Funchal
Contributes reviews on supplier material. Based in Funchal.
Joined 15 November 2024 · last posted 1d
93Posts here
2Topics
0Solutions
506Likes received
942Likes given
23Badges
188Days visited
2.3kPosts read
Recent activity
Full stream-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #43 · Clinical › Bloodwork · 27 Jul 2026 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Stepping down deliberately, and how to do it without losing progress — what changed since Replied, post #82 · Practice › Dosing & titration · 20 Jul 2026 · 0 likes On post #78 — agreed on the reasoning, with one qualification. Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #82 · Meta › Announcements · 13 Jul 2026 · 2 likes Staff announcements, policy changes, and scheduled maintenance. Read-only except for questions clarifying what was announced.
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #8 · Practice › Interactions · 9 Jul 2026 · 10 likes This follows post #5 rather than contradicting it. Anticoagulants: no direct interaction with the compounds in this class. Weight loss and body composition changes…
-
Prescription requirements and telehealth models — a second dataset Replied, post #94 · Sourcing › Regulatory · 6 Jul 2026 · 5 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Naming conventions for research peptides and the confusion they cause Replied, post #26 · Compounds › Other compounds · 6 Jul 2026 · 26 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #27 · Evidence › Journal club · 5 Jul 2026 · 32 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Prescription portability between countries Replied, post #76 · Access › International · 25 Jun 2026 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #82 · Safety › Contraindications · 21 Jun 2026 · 13 likes On post #78 — agreed on the reasoning, with one qualification. Severe hepatic impairment: less is known than for kidney disease. Extreme caution or contraindication…
-
Packaging that arrived damaged: documenting it properly Replied, post #28 · Sourcing › Logistics · 20 Jun 2026 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #20 · Pharmacology › Receptor biology · 17 Jun 2026 · 3 likes Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #32 · Pharmacology › Formulation chemistry · 17 Jun 2026 · 31 likes Emulsification and suspensions: some formulations are emulsions or suspensions rather than solutions. Semaglutide formulations are solutions; some other compounds are…